128053-Thumbnail Image.png

Dengue virus (DV) infections cause undisputedly the most important arthropod-borne viral disease in terms of worldwide prevalence, human suffering, and cost. Worldwide DV infection prevalence in 2010 was between 284 to 528 million cases. Approximately 84% of these cases come…

Dengue virus (DV) infections cause undisputedly the most important arthropod-borne viral disease in terms of worldwide prevalence, human suffering, and cost. Worldwide DV infection prevalence in 2010 was between 284 to 528 million cases. Approximately 84% of these cases come from Asia and the Americas, where the cost for emerging economies can be as high as 580 million dollars per year. Thus, the need for an efficient vaccine against DV is extreme.

Copyright Statement
    • Reuse Permissions
    • Downloads
    PDF (746.5 KB)

    Details

    Title
    • Dengue Vaccines: Strongly Sought But Not a Reality Just Yet
    Contributors
    Date Created
    2013-10-03
    Resource Type
  • Text
    • Collections this item is in
    ASU Scholarship Showcase
    Identifier
    • Digital object identifier: 10.1371/journal.ppat.1003551
    • International standard serial number
      1553-7366
    • International standard serial number
      1553-7374
    Note
    • The article is published at http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1003551

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Angel, R. M., & Valle, J. R. (2013). Dengue Vaccines: Strongly Sought but Not a Reality Just Yet. PLoS Pathogens, 9(10). doi:10.1371/journal.ppat.1003551

    Machine-readable links